BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34533756)

  • 1. Can acute exacerbations occurring late after surgery with interstitial lung diseases be predicted?
    Ichinokawa H; Takamochi K; Nojiri S; Fukui M; Hattori A; Matsunaga T; Suzuki K
    Gen Thorac Cardiovasc Surg; 2022 Feb; 70(2):160-169. PubMed ID: 34533756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
    Ozawa Y; Shibamoto Y; Hiroshima M; Nakagawa M; Ono A; Hanaoka R; Yamamoto A; Tominaga J; Kawada H; Koyama M; Takumi K; Tsubakimoto M; Egashira R; Tsushima F; Kikuchi Y; Izumi Y; Ushio T; Kimura M; Ichikawa S; Kitamura N; Matsushita S; Okauchi K; O'uchi T; Ishikawa H; Kitase M
    AJR Am J Roentgenol; 2021 Oct; 217(4):859-869. PubMed ID: 33852356
    [No Abstract]   [Full Text] [Related]  

  • 3. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
    Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
    Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis.
    Izuka S; Yamashita H; Iba A; Takahashi Y; Kaneko H
    Rheumatology (Oxford); 2021 May; 60(5):2348-2354. PubMed ID: 33241299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
    Kenmotsu H; Naito T; Kimura M; Ono A; Shukuya T; Nakamura Y; Tsuya A; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
    J Thorac Oncol; 2011 Jul; 6(7):1242-6. PubMed ID: 21623239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
    Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
    BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study.
    Hyun DG; Han SJ; Ji W; Choi CM; Lee JC; Kim HC
    Thorac Cancer; 2023 Nov; 14(33):3323-3330. PubMed ID: 37772425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
    Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
    Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy.
    Sekine A; Matama G; Hagiwara E; Tabata E; Ikeda S; Oda T; Okuda R; Kitamura H; Baba T; Satoh H; Misumi T; Komatsu S; Iwasawa T; Ogura T
    Thorac Cancer; 2022 Sep; 13(17):2443-2449. PubMed ID: 35840339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
    Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
    Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.